Depot Formulation and its Type



 Depot formulations are a type of drug delivery system that allows for the slow release of medication over a prolonged period of time. These formulations are designed to provide long-lasting therapeutic effects, reduce the frequency of dosing, and improve patient adherence to medication regimens. Depot formulations have been used to treat a variety of diseases, including cancer, diabetes, schizophrenia, and opioid addiction.

Depot formulations can be classified into several types based on their composition, release mechanism, and administration route. Some common types of depot formulations include:

  1. Injectable Depots: Injectable depots are formulations that are administered via injection and form a solid or semisolid depot at the injection site. These depots can slowly release the medication over a period of weeks to months. Injectable depots can be composed of biodegradable polymers, lipids, or inorganic materials.

Biodegradable polymers, such as poly(lactic-co-glycolic acid) (PLGA) and poly(caprolactone) (PCL), have been extensively used to develop injectable depots. These polymers can be tailored to degrade at a specific rate, allowing for the controlled release of medication. Injectable depots composed of lipids, such as long-chain fatty acids, have also been developed for the sustained release of medication.

  1. Implantable Depots: Implantable depots are formulations that are surgically implanted into the body and release medication over a period of months to years. Implantable depots can be composed of biodegradable or non-biodegradable materials.

One of the most common implantable depots is the etonogestrel implant, which is a small, flexible rod that is implanted into the upper arm to provide long-term contraception. The etonogestrel implant is composed of a non-biodegradable polymer and releases the medication over a period of three years.

Biodegradable implantable depots, such as PLGA and PCL, have also been developed for the sustained release of medication. These depots can be tailored to degrade at a specific rate, allowing for the controlled release of medication over a prolonged period of time.

  1. Transdermal Depots: Transdermal depots are formulations that are applied to the skin and release medication over a period of days to weeks. Transdermal depots can be composed of a variety of materials, including polymers, lipids, and hydrogels.

One of the most common transdermal depots is the nicotine patch, which is used to help people quit smoking. The nicotine patch is composed of a polymer matrix that slowly releases nicotine over a period of 24 hours. Other transdermal depots, such as lidocaine patches, have also been developed for the treatment of pain.

  1. Intrauterine Depots: Intrauterine depots are formulations that are inserted into the uterus and release medication over a period of months to years. Intrauterine depots can be composed of a variety of materials, including copper, levonorgestrel, and progesterone.

One of the most common intrauterine depots is the levonorgestrel-releasing intrauterine system (LNG-IUS), which is used for contraception. The LNG-IUS is composed of a small, T-shaped plastic frame that is inserted into the uterus and releases levonorgestrel over a period of five years.

  1. Oral Depots: Oral depots are formulations that are taken orally and release medication over a period of hours to days. Oral depots can be composed of a variety of materials, including polymers and lipids.

One of the most common oral depots is the extended-release tablet, which is designed to release medication over a prolonged period of time. Extended-release

Comments

Post a Comment

Popular posts from this blog

PLANT LAYOUT FOR CAPSULE MANUFACTURING DEPARTMENT & MANUFACTURING PROCESS

Image
PLANT LAYOUT  FOR CAPSULE MANUFACTURING DEPARTMENT: ENVIRONMENT CONDITION FOR CAPSULE FILLING AREA Humidity:          Not more than 35% RH Temperature:    Not more than 25% Area of each room, position of equipments, washing, drying, and sanitary facilities must be in accordance with GMP. MANUFACTURING PROCESS: CHEMCAPS Limited is an India based young and dynamic organization engaged in the manufacture and export of 'empty hard gelatin capsules' under the brand name of 'Chemlock' for discerning customers around the globe. COMPOSITION                                     Gelatin                                     Water                                     Colorants                                     Opecifier (TiO2 Dyes and Other)                                     Preservative MANUFACTURING OF HGC SHELL: SFR-901 FULLY AUTOMATIC CAPSULE MACHINE: FEATURES OF SFR-901 Ø   The Safrroys SFR-901 mod
Keep reading

2. Extensive literature survey:

Image
Once the problem is formulated, a brief summary of it should be written down. It is compulsory for a research worker writing a thesis for a Ph.D. degree to write a synopsis of the topic and submit it to the necessary Committee or the Research Board for approval.   At this juncture the researcher should undertake extensive literature survey connected with the problem. For this purpose, the abstracting and indexing journals and published or unpublished bibliographies are the first place to go to. Academic journals, conference proceedings, government reports, books etc., must be tapped depending on the nature of the problem. In this process, it should be remembered that one source will lead to another. The earlier studies, if any, which are similar to the study in hand, should be carefully studied. A good library will be a great help to the researcher at this stage.
Keep reading

PREPARATION OF HOSPITAL FORMULARY

Image
PREPARATION OF FORMULARY ·          Formulation is an essential part of hospital pharmacy. ·          It has been a focal point for improving drug therapy in hospitals. ·          Effectiveness of formulary system depends on the abilities of the pharmacist involved with it. ·          Although the majority of formulary decisions are made by Pharmacy and Therapeutic Committee but well planned system provides both structure and flexibility and encompasses both selection of drugs and criteria for drug use. ·          These special features allow for standardization to reduce errors, wastage and required personnel time. Advantage: ·          To discourage the use of “less than optimal drug therapy”, and ·          To provide generic product list. o    Generic product selection policies stimulate bio-equivalency comparison which prevents the unnecessary stocking of less than optimal products. ·          Formularies must include cost to provide relative cost data
Keep reading

Facebook Page

Knowledge of Pharma